In conclusion, our study demonstrates that FOXA1 drives NPC progression and cisplatin resistance via transcriptional regulation of BMI1, expanding its epigenetic role as a modulator of chromatin remodeling. Here, FOXA1 is linked to nasopharyngeal carcinoma.